Bioorganic and Medicinal Chemistry p. 2111 - 2126 (1998)
Update date:2022-09-26
Topics:
Homan, Evert J.
Copinga, Swier
Elfstroem, Lotta
Van Der Veen, Trees
Hallema, Jan-Pieter
Mohell, Nina
Unelius, Lena
Johansson, Rolf
Wikstroem, Hakan V.
Grol, Cor J.
A new chemical class of potential atypical antypsychotic agents, based on the pharmacological concept of mixed dopamine D2 receptor antagonism and serotonin 5-HT(1A) receptor agonism, was designed by combining the structural features of the 2-(N,N-di-n-propylamino)tetralins (DPATs) and the 2-pyrrolidinylmethyl-derived substituted benzamides in a structural hybrid. Thus, a series of 35 differently substituted 2-aminotetralin-derived substituted benzamides was synthesized and the compounds were evaluated for their ability to compete for [3H]-raclopride binding to cloned human dopamine D(2A) and D3 receptors, and for [3H]-8-OH-DPAT binding to rat serotonin 5-HT(1A) receptors in vitro. The lead compound of the series, 5-methoxy-2-[N-(2-benzamidoethyl)-N-n-propylamino]tetralin (12a), displayed high affinities for the dopamine D(2A) receptor (K(i)=3.2nM), the dopamine D3 receptor (K(i)=0.58nM) as well as the serotonin 5-HT(1A) receptor (K(i)=0.82nM). The structure-affinity relationships of the series suggest that the 2-aminotetralin moieties of the compounds occupy the same binding sites as the DPATs in all three receptor subtypes. The benzamidoethyl side chain enhances the affinities of the compounds for all three receptor subtypes, presumably by occupying an accessory binding site. For the dopamine D2 and D3 receptors, this accessory binding site may be identical to the binding site of the 2-pyrrolidinylmethyl-derived substituted benzamides. Copyright (C) 1998 Elsevier Science Ltd.
View MoreContact:+86-574-87065746
Address:10th Floor, No.787 Baizhang East Road,
Wuxi Pharma-Trading Import & Export Co.,Ltd.
Contact:+86-510-82304590 82716390
Address:Room 523,Youzu Alliance Building,No.88 Renmin Zhonglu,Wuxi,Jiangsu,China
Guangzhou Chemical Reagent Factory
Contact:+86-20-8435 9820 or 8435 7345
Address:Southern Guangzhou, Guangdong, China
Compro Shijiazhuang Fine Chemical Co., Ltd
Contact:0086-311-89689838
Address:Economic and Technological Development Zone of Shijiazhuang,Hebei
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Doi:10.1016/j.tet.2008.08.040
(2008)Doi:10.1021/ja993774s
(2000)Doi:10.1021/ja01281a052
(1937)Doi:10.1021/ja00525a029
(1980)Doi:10.1016/S0022-328X(00)85813-1
(1981)Doi:10.1016/j.saa.2012.11.046
(2013)